Disease/Infection News

RSS

Using AI to find optimal combination of available therapies against SARS-CoV-2

A team of researchers from the National University of Singapore has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19.

10 Dec 2020

"Living" systematic review captures and updates evidence on "long COVID"

Researchers in the United Kingdom have set up a “living” systematic review in response to the rapidly emerging evidence-base for “long COVID” – the term used to refer to coronavirus disease 2019 (COVID-19) symptoms that persist for longer than would usually be expected.

10 Dec 2020

KHN’s ‘What the Health?’: Vaccines coming soon but COVID relief bill still stalled

The first vaccine to protect against COVID-19 could be approved in the U.S. within days, but legislation to help fund its distribution remains mired in Congress.

10 Dec 2020

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Now, a study on the utility of hydroxychloroquine as prophylaxis against COVID-19, has been released in the latest issue of Annals of Internal Medicine.

10 Dec 2020

SARS-CoV-2 infection in pets in COVID-19 positive households: A case study

Researchers tested cats and dogs living in households with COVID-19 positive owners in Texas, US. They found that the pets were also infected in more than 25% of households with a positive case.

10 Dec 2020

Reverse phenotyping shows reactive T cell profiles in SARS-CoV-2 infection

A new study appearing as a preprint on the medRxiv* browser in December 2020 employs reverse phenotyping technology to explore T cell responses in COVID-19.

10 Dec 2020

Single N primer sufficient for SARS-CoV-2 molecular diagnosis

There is a huge and growing demand for better molecular diagnostic tests for COVID-19, as the pandemic shows few signs of coming under control.

10 Dec 2020

MEDS433 hinders SARS-CoV-2 replication

A paper that recently appeared in the preprint server bioRxiv* reports the powerful activity of a compound named MEDS433 against this virus.

10 Dec 2020

A battle-weary Seattle hospital fights the latest COVID surge

As hospitals across the country weather a surge of COVID-19 patients, in Seattle — an early epicenter of the outbreak — nurses, respiratory therapists and physicians are staring down a startling resurgence of the coronavirus that’s expected to test even one of the best-prepared hospitals on the pandemic’s front lines.

10 Dec 2020

SARS-CoV-2 spike protein mediates acute lung pathology in mice

A study shows that the viral spike protein is adequate by itself to induce macrophage activation in pulmonary tissue and induce acute inflammation.

10 Dec 2020

Severe cortical damage associated with COVID-19 case report

In December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began to cause a flu-like infection in people living in Wuhan, China.

10 Dec 2020

Mental distress increases among smokers in England during COVID-19 pandemic

Scientists have conducted a survey in England to investigate the association between smoking habits and distress during the COVID-19 pandemic.

10 Dec 2020

Could anterior nasal swabs be an effective alternative for SARS-CoV-2 testing?

Researchers from various institutions in Germany and Switzerland recently performed a prospective diagnostic accuracy study, in which they compared professional-collected anterior nasal swabs to nasopharyngeal swabs, using WHO-listed SARS-CoV-2 Ag-RDT (STANDARD Q COVID-19 Ag Test, SD Biosensor) test kits.

10 Dec 2020

Pioneering diagnostics platform changes the way COVID-19 is detected

Montreal-based Two-Photon Research Inc. announces CAST, a diagnostics platform that changes the way viruses are detected. The CAST platform uses TPR’s patented Aptamer Molecular Photonic Beacon™ that photonically interfaces with smartphones.

10 Dec 2020

Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication

A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.

10 Dec 2020

Effective adoption of digital technology underpins businesses’ response to COVID-19

Increased adoption of new digital technology has underpinned businesses’ response to COVID-19, with four in ten citing it as both vital to retaining jobs, and the ongoing viability of their business model, according to a new report from the University of Liverpool.

10 Dec 2020

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.

From EKF Diagnostics 10 Dec 2020

National lung health organizations urge universal vaccine adoption to end COVID-19 pandemic

As COVID-19 cases surge in the U.S., the nation is waiting for the availability of a safe and effective vaccine.

10 Dec 2020

Risk of COVID infection in health care workers is driven by community exposure

Nurses only group with higher risk once community exposure considered. Largest cohort of health care worker risk for SARS CoV-2. Only high-flow oxygen therapy and hemodialysis linked to more antibodies to SARS-CoV-2.

10 Dec 2020

Proactive management of COVID-19 risk can support employees' return to work

A Journal of Prevention, Assessment & Rehabilitation, published by IOS Press, is committed to helping organizations manage the challenges they face during the COVID-19 pandemic by publishing robust, evidence-based research, and commentary. All articles featured here and in the WORK COVID-19 Collection are freely available.

9 Dec 2020